Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
featured
A Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

A Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

stage iv non-small cell lung cancer
lung carcinoma
systemic therapy
cancer chemotherapy
non-small cell carcinoma
  • 640 views
  • 24 Nov, 2020
  • 1 location
featured
Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

  • 128 views
  • 08 Nov, 2020
  • 1 location
featured
Advanced Stage Non-small Cell Lung Cancer

Advanced Stage Non-small Cell Lung Cancer

  • 200 views
  • 08 Nov, 2020
  • 1 location
Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer

This is a phase II trial of durvalumab in combination of platinum-based chemotherapy. Patients with stage IV Non-Small-Cell-Lung Cancer (NSCLC) with human immunodeficiency virus (HIV) infection

pemetrexed
lung carcinoma
systemic therapy
platelet count
cancer chemotherapy
  • 0 views
  • 02 Jun, 2021
  • 3 locations
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

diagnosed with advanced (stage IV) NSCLC, irrespective of PD-L1 status, and who have oligoprogressed to both immunotherapy with an anti PD-1 agent (e.g., pembrolizumab or nivolumab) and 1 line of

  • 0 views
  • 06 Mar, 2021
  • 1 location
Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer

Trial Design Patients with stage IV non-small cell lung cancer are randomized to nivolumab/ipilimumab plus either sequential or concurrent stereotactic body radiotherapy (SBRT

  • 10 views
  • 27 Jan, 2021
  • 1 location
OMEGA Local Ablative Therapy in Oligometastatic NSCLC

Oligometastatic lung cancer (OM-NSCLC) seems to be associated with a better prognosis than usual Stage IV non-small cell lung cancer when radical local therapy of all metastatic sites is

stage iv non-small cell lung cancer
lung carcinoma
brain metastases
cancer chemotherapy
ct scan
  • 0 views
  • 23 Jan, 2021
  • 1 location
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

The primary objective of this study is to evaluate the tolerability and the maximum tolerated dose of Conformal or Intensity-Modulated Radiotherapy when given in combination with gefitinib 250mg in Chinese patients with IIIB or IV NSCLC after failure of platinum-based chemotherapy. Secondary objectives of the study are to obtain the …

pleural effusion
cancer chemotherapy
metastasis
gefitinib
platinum-based chemotherapy
  • 1 views
  • 07 Nov, 2020
  • 1 location
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

In this phase II trial with single arm, we aim to investigate the clinical efficacy and toxicity profile of local radiotherapy on all disease sites for EGFR-mutant oligo-metastatic NSCLC (no more than 3 metastatic lesions) who did not experience disease progression after at least 3 months of TKI therapy.

EGFR
  • 0 views
  • 23 Jan, 2021
  • 1 location
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

This randomized phase II/III trial studies how well giving maintenance chemotherapy with or without local consolidation therapy works in treating patients with stage IV non-small cell lung

stage iv non-small cell lung cancer
pemetrexed
tumor cells
metastasis
stereotactic body radiation therapy
  • 238 views
  • 06 Jun, 2021
  • 194 locations